IRIDEX CORP Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated June 12, 2026, reports on the status of IRIDEX Corporation's 2026 Annual Meeting of Stockholders. The Company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol IRIX.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and contains no financial data.
Material Changes
The primary event reported is the adjournment of the 2026 Annual Meeting without conducting business. No changes have been made to the proposals to be voted on by stockholders. The record date for voting remains April 17, 2026.
Guidance, Outlook, and Risks
The Annual Meeting is scheduled to reconvene at 8:00 a.m. Pacific Time on Friday, July 10, 2026. The meeting will be held in person at the Company's principal executive offices in Mountain View, California. Proxies previously submitted remain valid unless properly revoked, and stockholders who have already voted need not take further action. The filing does not disclose new risks, contingencies, or unusual items.
Key Facts for Investors
- The 2026 Annual Meeting was adjourned on June 12, 2026, without business conducted.
- The meeting is rescheduled for July 10, 2026, at 8:00 a.m. Pacific Time.
- The meeting location remains 1212 Terra Bella Avenue, Mountain View, California.
- Existing proxies and votes remain valid for the rescheduled date.
- No financial results or guidance are included in this filing.